Eyeing A Challenge to a Blockbuster

https://is1-ssl.mzstatic.com/image/thumb/Podcasts125/v4/4d/06/80/4d068008-4092-58f8-6592-f900e2d86508/mza_5090466875224206838.jpeg/600x600bb.jpg

RARECast

570 episodes

1 week ago

RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy.

Business

RSS

All content for RARECast is the property of RARECast and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy.

Business

https://content.production.cdn.art19.com/images/78/62/a0/61/7862a061-1aa5-444e-930f-1ae380f2243f/2d4db572ece3b5f6f2226f0fd6a05549552ced99839225e9ca281c4efc9f05c4d01c0bd056920ee48155e9ac30d73d97d96d460f45cd0dd760e9a62efea54909.jpeg

Eyeing A Challenge to a Blockbuster

RARECast

40 minutes 4 seconds

4 months ago

Eyeing A Challenge to a Blockbuster

Steve Mahoney, CEO of Viridian Therapeutics, discusses the complexities of thyroid eye disease, the challenges of living with the condition, and why veligrotug has the potential to provide a new alternative for people living with the condition.